Medical and Pharmaceutical

Zenabis Global Inc (TSX-V:ZENA) announced it is partnering with a pharmaceutical company based out of Germany, Farmako. The two companies are going to be working together on a couple of initiatives, including selling CBD isolate oil in Canada along with selling cannabis to the German medical market.

Columbia Care Inc. (NEO:CCHW) launched on the NEO exchange, becoming the first cannabis company to list on the exchange with a market capitalization of more than a billion dollars.

The Green Organic Dutchman Holdings Ltd (TSX:TGOD) announced last week that its facility in Hamilton, Ontario received a license from Health Canada to sell cannabis oil.

There is a big bill circulating the U.S. government that could have a big impact on the cannabis industry. The Strengthening the Tenth Amendment Through Entrusting States (STATES) Act could lead to significant opportunities in the U.S. It could help open the door to more consolidation of U.S. and Canadian operations and lead to more mergers and acquisitions. Here are five companies to watch for if the bill passes.

Cannabidiol, or CBD, is being touted as a cure-all for everything from anxiety to insomnia but is it good for breastfeeding mothers?

April 20, aka 4/20, is coming up and one way cannabis enthusiasts can celebrate it is with a CBD-infused burger from fast-food chain Carl's Jr. According to the Company, it has enough supply to be able to sell at least 1,000 burgers containing CBD.

The State of Colorado recently updated its sales numbers for cannabis, and they're continuing to slide. With $119 million in sales for February, it was the lowest month that the State had since February of last year when it earned $113 million. It was also the second consecutive month that total cannabis sales were down.

Aphria Inc (TSX:APHA)(NYSE:APHA) and Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) have been very active when it comes to international expansion. And now, the two companies will be able to compete head-on in the German cannabis market.

Marijuana bills across the US made significant progress in various parts of the country. Is more to come?

Lab-made marijuana? Recently, at the University of California in Berkeley, scientists were able to create cannabis compounds without needing to use a plant to harvest them.

Colorado Governor Jared Polis signed a bill that would allow medical marijuana use to be expanded to include autism as a qualifying medical condition.

Back in November of 2018, the State of Michigan officially opened for business when its first medical marijuana dispensary opened. Besides a slow first month where sales hit $7.1 million, the State has seen sales average over $11 million since then.

This past week, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) got a boost in price when analysts at Cowen Inc., an investment bank in the U.S., said that Aurora was its top pick for the sector.

While it might seem odd to some people, many pet owners have been using cannabis to help treat pets that are suffering in pain, relying on the medicinal benefits of cannabidiol (CBD). The danger, however, is when pets are exposed to tetrahydrocannabinol (THC), the high-inducing substance.

The rave reviews that cannabidiol (CBD) has been earning from many patients has not gone unnoticed. Many athletes use CBD, including those that play in the National Hockey League (NHL). And recently, the NHL Alumni Association agreed to work with cannabis giant Canopy Growth Corp. to conduct one or more studies relating to its use.

It's not hard to find anecdotes of how CBD has helped provide patients with pain relief, normally after exhausting all other options. The problem, however, is that there isn't a lot of data behind those claims and finding hard facts and numbers on the effectiveness of CBD is very difficult.

Medical marijuana has been generating a lot of interest around the world for its ability to treat many different diseases and ailments. A recent study out of Penn State College also suggests that it could it could be used to treat cancer cells as well.

How the cannabis retail market will look remains one of the marijuana's sector's biggest unknowns. Here is an overview of four big cannabis companies and their very different approaches for gaining market share in the retail space.

In late 2016 and early 2017, Organigram Holdings Inc (TSXV:OGI) began voluntary recalls of its medical marijuana products after pesticides which were not permitted to be used on cannabis, as per the Pest Control Products Act, were detected. The recalls fell into hazard categories II and III, which suggested that at worst, there might be temporary side effects for affected customers...now here comes the lawsuits.

Medical marijuana patients in Ontario can now make cannabis purchases online through Shoppers Drug Mart's new website. The website recently launched and is designed for patients and provides information for consumers interested in learning more about medical marijuana. Here's how it stacks up against the others.

Cannabis can be purchased in-store, online, and it can even be picked up in a drive-thru. For consumers in Vermont, the option is now available in Brattleboro. Ceres Natural Remedies sells hemp-derived cannabidiol (CBD) - which was recently legalized - and has opened the company's first drive-thru where consumers can pick up cannabis the same way they might get their fast food. While it's not the first one in the country, it's by no means prevalent just yet.

Tilray Inc (NASDAQ:TLRY) shares jumped Tuesday as the Company announced it would be working with pharmaceutical company Sandoz AG to make medical marijuana products available around the globe. Tilray already has a presence in a dozen countries and this will help accelerate the company's incredible growth.